✦ LIBER ✦

The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation

✍ Scribed by Jeremy D. Gale

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tegaserod is effective in the initial an

✍ S. Müller-Lissner; G. Holtmann; P. Rueegg; G. Weidinger; H. Löffler 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 949 KB

Epidemiology of functional constipation

✍ Y.-F. Zhao; X.-Q. Ma; R. Wang; X.-Y. Yan; Z.-S. Li; D.-W. Zou; J. He 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB

Pilot study of the efficacy of renzaprid

✍ J. TACK; S. J. MIDDLETON; M. C. HORNE; H. PIESSEVAUX; J. S. BLOOR; N. L. MEYERS; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB

Review article: the role of serotonergic

✍ B. D. CASH; W. D. CHEY 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB

The effect of fluoxetine in patients wit

✍ H. VAHEDI; S. MERAT; A. RASHIDIOON; A. GHODDOOSI; R. MALEKZADEH 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

The effects of withdrawing tegaserod tre

✍ K. D. Bardhan; A. Forbes; C. L. Marsden; T. Mason; G. Short 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 421 KB